T cell-intrinsic ASC critically promotes T H 17-mediated experimental autoimmune encephalomyelitis

Nature Immunology

Volumn 17, Issue 5, 2016, Pages 583-592

  Martin, Bradley N ^a,b   Wang, Chenhui ^a,c   Zhang, Cun Jin ^a,d   Kang, Zizhen ^e   Gulen, Muhammet Fatih ^a   Zepp, Jarod A ^a   Zhao, Junjie ^a   Bian, Guanglin ^a   Do, Jeong Su ^a   Min, Booki ^a   Pavicic, Paul G ^a   El Sanadi, Caroline ^b   Fox, Paul L ^a   Akitsu, Aoi ^f   Iwakura, Yoichiro ^f   Sarkar, Anasuya ^g   Wewers, Mark D ^g   Kaiser, William J ^h   Mocarski, Edward S ^h   Rothenberg, Marc E ⁱ   Hise, Amy G ^b   Dubyak, George R ^b   Ransohoff, Richard M ^a,j   Li, Xiaoxia ^a   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

^g OHIO STATE UNIVERSITY   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j BIOGEN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 8; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; T LYMPHOCYTE RECEPTOR; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; INTERLEUKIN 17; NLRP3 PROTEIN, MOUSE; PYCARD PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; SURVIVAL; TH1 CELL; TH17 CELL; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOBLOTTING; INFLAMMASOMES; INTERLEUKIN-17; INTERLEUKIN-1BETA; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TH17 CELLS;

EID: 84961392860     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3389     Document Type: Article

References (47)

1. Frohman, E.M. Multiple sclerosis. Med. Clin. North Am. 87, 867-897 (2003).
2. Ransohoff, R.M. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15, 1074-1077 (2012).
3. Stromnes, I.M., Cerretti, L.M., Liggitt, D., Harris, R.A., Goverman, J.M. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nat. Med. 14, 337-342 (2008).
4. Kroenke, M.A., Carlson, T.J., Andjelkovic, A.V., Segal, B.M. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205, 1535-1541 (2008).
5. Lees, J.R., Golumbek, P.T., Sim, J., Dorsey, D., Russell, J.H. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205, 2633-2642 (2008).
6. Jäger, A., Dardalhon, V., Sobel, R.A., Bettelli, E., Kuchroo, V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009).
7. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
8. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., Stockinger, B. TGF? in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
9. Mangan, P.R. et al. Transforming growth factor-α induces development of the TH17 lineage. Nature 441, 231-234 (2006).
10. Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 (2009).
11. Gulen, M.F. et al. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32, 54-66 (2010).
12. Staschke, K.A. et al. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease. J. Immunol. 183, 568-577 (2009).
13. Matsuki, T., Nakae, S., Sudo, K., Horai, R., Iwakura, Y. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int. Immunol. 18, 399-407 (2006).
14. Gulen, M.F. et al. Inactivation of the enzyme GSK3? by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance. Immunity 37, 800-812 (2012).
15. Chang, J. et al. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc. Natl. Acad. Sci. USA 110, 2270-2275 (2013).
16. Gris, D. et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981 (2010).
17. Inoue, M., Williams, K.L., Gunn, M.D., Shinohara, M.L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 109, 10480-10485 (2012).
18. Inoue, M. et al. Interferon-? therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci. Signal. 5, ra38 (2012).
19. Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263 (2011).
20. Arbeloa, J., Perez-Samartin, A., Gottlieb, M., Matute, C. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol. Dis. 45, 954-961 (2012).
21. Qu, Y. et al. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561 (2011).
22. Gordon, G.R. et al. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat. Neurosci. 8, 1078-1086 (2005).
23. Antonopoulos, C., El Sanadi, C., Kaiser, W.J., Mocarski, E.S., Dubyak, G.R. Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J. Immunol. 191, 4789-4803 (2013).
24. Gringhuis, S.I. et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13, 246-254 (2012).
25. Bossaller, L. et al. FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J. Immunol. 189, 5508-5512 (2012).
26. Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367 (2011).
27. Leverrier, S., Salvesen, G.S., Walsh, C.M. Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ. 18, 90-98 (2011).
28. Bell, B.D. et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. USA 105, 16677-16682 (2008).
29. Kang, T.B. et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173, 2976-2984 (2004).
30. Salmena, L. et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17, 883-895 (2003).
31. Chun, H.J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395-399 (2002).
32. Bauernfeind, F.G. et al. NF-?B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787-791 (2009).
33. Martin, B.N. et al. IKK? negatively regulates ASC-dependent inflammasome activation. Nat. Commun. 5, 4977 (2014).
34. Bryan, N.B., Dorfleutner, A., Rojanasakul, Y., Stehlik, C. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J. Immunol. 182, 3173-3182 (2009).
35. Schenten, D. et al. Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells. Immunity 40, 78-90 (2014).
36. Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509-514 (2014).
37. Shaw, P.J. et al. Critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4610-4614 (2010).
38. El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568-575 (2011).
39. Wei, D.G. et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202, 239-248 (2005).
40. Shornick, L.P. et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 183, 1427-1436 (1996).
41. Tomalka, J. et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog. 7, e1002379 (2011).
42. Sarkar, A. et al. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independent of interleukin-1β and interleukin-18. Am. J. Respir. Crit. Care Med. 174, 1003-1010 (2006).
43. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003 (1995).
44. Kaiser, W.J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372 (2011).
45. Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247-256 (2007).
46. Kang, Z. et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414-425 (2010).
47. Suzuki, S. et al. Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkc?. PLoS Pathog. 10, e1003926 (2014).